Trastuzumab: updates and future issues

By Toi Masakazu   Horiguchi Kazumi   Bando Hiroko   Saji Shigehira   Chow Louis  

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 94-99

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 2, 2012-02 ,pp. : 151-162

Bentham Science Publishers

Access to resources Recommend Favorite

Future directions in the adjuvant treatment of breast cancer: The role of trastuzumab

By Smith I.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 75-79

Springer Publishing Company

Access to resources Recommend Favorite

Editorial [Hot Topic: Natural Compounds as Cancer Chemopreventive and Chemotherapeutic Agents: Insights Gained from Mechanistic and Pharmacologic Studies]

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 10, 2012-12 ,pp. : 1157-1158

Bentham Science Publishers

Access to resources Recommend Favorite

Trastuzumab Monotherapy

By Vogel Charles  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 67-68

Springer Publishing Company

Access to resources Recommend Favorite